Unichem Laboratories

Unichem Laboratories, founded in 1944, is a prominent pharmaceutical entity based in India. The company specializes in the research, development, and manufacturing of high-quality pharmaceutical products. With a focus on innovation, Unichem Laboratories leverages advanced technologies to produce immediate and extended-release dosage forms, OROS technology, and specialized dry powder injections and syrups. The firm maintains a robust operational footprint across 6 global locations, supporting its mission to provide superior healthcare solutions.

The organization operates with a workforce of 1,000-5,000 employees, driving its research-oriented pharmaceutical initiatives. Unichem Laboratories is recognized for its integrated pharmaceutical capabilities, including the production of generic formulations that meet stringent international standards. Meet Unichem Laboratories's team to understand the leadership and technical expertise behind their drug development processes. Their commitment to better health is reflected in their rigorous adherence to regulatory requirements and their focus on delivering effective therapeutic options to diverse markets.

As a publicly traded entity on the NSE under the ticker UNICHEMLAB, the company continues to expand its influence within the global healthcare sector. With annual revenue reaching $203.9M, Unichem Laboratories maintains a strong competitive position by prioritizing R&D and maintaining high-quality manufacturing standards. The company’s strategic focus on generic formulations and innovative delivery systems ensures its continued relevance in the evolving pharmaceutical landscape. By integrating advanced manufacturing processes with a deep commitment to patient care, Unichem Laboratories remains a key player in the international pharmaceutical industry, consistently delivering value through its comprehensive product portfolio and research-driven approach.